The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813906 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elena Adinolfi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Neoplasms, Carcinogenesis, Adenosine. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Cooperation in Science and Technology, Italian Association for Cancer Research, TRANSCAN-3 JTC2021.
Abstract (Originalsprache)
The tumor niche is an environment rich in extracellular ATP (eATP) where purinergic receptors have essential roles in different cell subtypes, including cancer, immune, and stromal cells. Here, we give an overview of recent discoveries regarding the role of probably the best-characterized purinergic receptor in the tumor microenvironment: P2X7. We cover the activities of the P2X7 receptor and its human splice variants in solid and liquid cancer proliferation, dissemination, and crosstalk with immune and endothelial cells. Particular attention is paid to the P2X7-dependent release of microvesicles and exosomes, their content, including ATP and miRNAs, and, in general, P2X7-activated mechanisms favoring metastatic spread and niche conditioning. Moreover, the emerging role of P2X7 in influencing the adenosinergic axis, formed by the ectonucleotidases CD39 and CD73 and the adenosine receptor A2A in cancer, is analyzed. Finally, we cover how antitumor therapy responses can be influenced by or can change P2X7 expression and function. This converging evidence suggests that P2X7 is an attractive therapeutic target for oncological conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Department of Biochemistry, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University in Torun, 87-100 Torun, Poland.
ORCID-Profile: Elena De Marchi, Bartosz Szymczak
Förderung
- European Cooperation in Science and Technology
- Italian Association for Cancer Research
- TRANSCAN-3 JTC2021
- COST (European Cooperation in Science and Technology)
- PUR-THER TRANSCAN-3
- University of Ferrara
Zitieren
APA
Adinolfi, E., De Marchi, E., Grignolo, M., Szymczak, B., & Pegoraro, A. (2023). The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813906
Vancouver
Adinolfi E, De Marchi E, Grignolo M, Szymczak B, Pegoraro A. The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813906
BibTeX
@article{Adinolfi2023,
author = {Adinolfi, Elena and De Marchi, Elena and Grignolo, Marianna and Szymczak, Bartosz and Pegoraro, Anna},
title = {The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813906}
}
EUVIMED